00
000930.SHE Cofco Biochemical Anhui Co Ltd
- Market cap
- CNY 8.76B
- P/E
- -
- P/B
- 0.82x
- ROE
- -1.2%
- Dividend yield
- 0.95%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000930.SHE undervalued?
Graham numberThe Graham number of Cofco Biochemical Anhui Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cofco Biochemical Anhui Co Ltd fundamental analysis
No fundamental analysis for Cofco Biochemical Anhui Co Ltd yet.
Cofco Biochemical Anhui Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cofco Biochemical Anhui Co Ltd
COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing of agricultural products in China. The company offers ethanol disinfectants, pharmaceutical ethanol, edible alcohol, anhydrous ethanol, and denatured fuel ethanol; edible corn starch; and flavoring, glucose, malt, and high fructose syrup. It also provides food additives and others, such as corn crude oil, phytosterol red yeast rice tea polyphenol tablets, natural vitamin E soft capsules,…
Full company profileCofco Biochemical Anhui Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cofco Biochemical Anhui Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.60B | 15.9B | 17.7B | 19.5B | 19.9B | 23.6B | 19.9B | 20.4B | 20.1B | 17.5B | 16.5B |
| Gross Profit | 735M | 2.38B | 2.76B | 2.62B | 1.82B | 2.44B | 2.08B | 581M | 1.15B | 1.46B | 924M |
| Operating Income | -80.0M | 997M | 614M | 660M | 806M | 1.37B | 1.35B | -572M | 71.5M | 494M | 65.3M |
| EBITDA | 465M | 1.92B | 1.40B | 1.26B | 1.34B | 1.97B | 1.89B | 37.1M | 719M | 685M | -17.5M |
| Net Income | 127M | 929M | 483M | 593M | 593M | 1.13B | 1.06B | -602M | 25.1M | 38.4M | -119M |
| EPS | 0.13 | 0.50 | 0.26 | 0.32 | 0.32 | 0.61 | 0.57 | -0.33 | 0.01 | 0.02 | -0.06 |
| Balance Sheet | |||||||||||
| Total Assets | 5.44B | 5.96B | 20.3B | 17.2B | 20.5B | 18.1B | 18.1B | 16.6B | 17.3B | 16.8B | 18.0B |
| Total Liabilities | 3.73B | 3.99B | 10.6B | 6.95B | 9.68B | 6.30B | 5.59B | 5.70B | 6.41B | 5.75B | 7.28B |
| Shareholders' Equity | 1.56B | 1.80B | 9.23B | 9.83B | 10.4B | 11.4B | 12.1B | 10.5B | 10.5B | 10.6B | 10.3B |
| Cash & Short-term Investments | 618M | 555M | 773M | 700M | 662M | 1.12B | 1.02B | 1.48B | 1.91B | 2.49B | 2.17B |
| Total Debt | 2.50B | 2.80B | 5.80B | 3.01B | 6.83B | 3.40B | 3.23B | 3.76B | 4.34B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 785M | 748M | -923M | 3.65B | -2.91B | 4.84B | 708M | 1.96B | 156M | 1.85B | - |
| Capital Expenditure | 161M | 639M | 868M | 901M | 988M | 1.11B | 566M | 635M | 483M | 674M | 936M |
| Free Cash Flow | 624M | 108M | -1.79B | 2.75B | -3.90B | 3.73B | 143M | 1.32B | -327M | 1.17B | -1.71B |
| Ratios | |||||||||||
| ROE | 8.1% | 51.5% | 5.2% | 6.0% | 5.7% | 9.9% | 8.7% | -5.8% | 0.2% | 0.4% | -1.2% |
| ROA | 2.3% | 15.6% | 2.4% | 3.5% | 2.9% | 6.3% | 5.8% | -3.6% | 0.1% | 0.2% | -0.7% |
| Net Profit Margin | 2.3% | 5.8% | 2.7% | 3.0% | 3.0% | 4.8% | 5.3% | -3.0% | 0.1% | 0.2% | -0.7% |
| Debt to Equity | 1.60x | 1.55x | 0.63x | 0.31x | 0.66x | 0.30x | 0.27x | 0.36x | 0.41x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cofco Biochemical Anhui Co Ltd dividends
- Dividend yield
- 0.95%
- Forward dividend
- 0.03 CNY
- Payout ratio
- 216.5%
- Ex-dividend date
- Jul 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 83.1M | 0.04 | 216.5% |
| 2024 | CNY 93.5M | 0.05 | 372.0% |
| 2023 | CNY 1.17B | 0.64 | - |
| 2022 | CNY 457M | 0.25 | 43.2% |
| 2021 | CNY 277M | 0.15 | 24.6% |
| 2020 | CNY 29.9M | 0.02 | 5.0% |
| 2019 | CNY 46.2M | 0.03 | 7.8% |
| 2018 | CNY 192M | 0.10 | 39.6% |
| 2017 | CNY 115M | 0.06 | 12.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Dec 7, 2005.
Who owns Cofco Biochemical Anhui Co Ltd
- Insiders 57.97%
- Institutions 0.88%
- Public & others 41.14%
- Shares outstanding 1.86B
- Free float 816M
Cofco Biochemical Anhui Co Ltd company profile
- Company name
- Cofco Biochemical Anhui Co Ltd
- Ticker
- 000930.SHE
- ISIN
- CNE000000ZR7
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Jun 21, 1999
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 4,571
- Fiscal year end
- December
- Address
- Building A, Chaoyang, China, 100020
- Phone
- 86 10 6504 7979
- Website
- cofco.com
About Cofco Biochemical Anhui Co Ltd
COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing of agricultural products in China. The company offers ethanol disinfectants, pharmaceutical ethanol, edible alcohol, anhydrous ethanol, and denatured fuel ethanol; edible corn starch; and flavoring, glucose, malt, and high fructose syrup. It also provides food additives and others, such as corn crude oil, phytosterol red yeast rice tea polyphenol tablets, natural vitamin E soft capsules, phytosterols, and vitamin E; corn germ meal, sprayed corn husks, corn protein powder, and corn dried alcohol distillers; and polylactic acid products. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd. in September 2019. The company was founded in 1998 and is based in Chaoyang, China.
Cofco Biochemical Anhui Co Ltd management
6- Mr. Changping HuChief Accountant & Financial Manager · born 1971
- Mr. Jinbo SuBoard Secretary · born 1979
- Mr. Rui QiaoDeputy General Manager · born 1972
- Mr. Shao Hui ChenDeputy General Manager · born 1969
- Mr. Bao ZhangDeputy General Manager · born 1971
- Mr. Manyi WangGM & Director · born 1982